Antituberculosis Targeted Drug Delivery as a Potential Future Treatment Approach
<i>Mycobacterium tuberculosis</i> (Mtb) is the microorganism that causes tuberculosis. This infectious disease has been around for centuries, with the earliest record of Mtb around three million years ago. The discovery of the antituberculosis agents in the 20th century has managed to im...
Main Authors: | Mohd Khairul Nizam Mazlan, Mohammad Hafizie Dianel Mohd Tazizi, Rosliza Ahmad, Muhammad Amirul Asyraf Noh, Athirah Bakhtiar, Habibah A. Wahab, Amirah Mohd Gazzali |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-07-01
|
Series: | Antibiotics |
Subjects: | |
Online Access: | https://www.mdpi.com/2079-6382/10/8/908 |
Similar Items
-
Deciphering the mechanism and function of stage-specific protein association with the membrane cytoskeleton of Toxoplasma gondii:
by: Dubey, Rashmi
Published: (2017) -
Nanotechnology and Drug Delivery: An Update in Oncology
by: Tait Jones, et al.
Published: (2011-04-01) -
Challenges of Current Anticancer Treatment Approaches with Focus on Liposomal Drug Delivery Systems
by: Vijay Gyanani, et al.
Published: (2021-08-01) -
Nanoparticles Targeting Receptors on Breast Cancer for Efficient Delivery of Chemotherapeutics
by: Sulltana Jahan, et al.
Published: (2021-01-01) -
Targeted Delivery to Tumors: Multidirectional Strategies to Improve Treatment Efficiency
by: Olga M. Kutova, et al.
Published: (2019-01-01)